Abcam plc (ABCM) Financials

NASDAQ:ABCM

Market Cap

5.20B

Total Revenue

361.70M

Gross Profit

270.50M

Operating Income

-10.20M

Net Income

-8.50M

Metric	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
revenue	122,206,000	127,954,000	144,033,000	171,673,000	217,098,000	233,200,000	259,900,000	260,000,000	315,400,000	361,700,000
costOfRevenue	35,500,000	37,569,000	42,507,000	51,142,000	64,998,000	70,200,000	76,700,000	79,800,000	90,800,000	91,200,000
grossProfit	86,706,000	90,385,000	101,526,000	120,531,000	152,100,000	163,000,000	183,200,000	180,200,000	224,600,000	270,500,000
researchAndDevelopmentExpenses	7,946,000	10,054,000	9,919,000	12,821,000	18,565,000	16,000,000	10,700,000	17,400,000	27,800,000	56,100,000
sellingAndMarketingExpenses	34,701,000	36,340,000	45,880,000	57,437,000	73,963,000	78,200,000	88,900,000	118,300,000	189,700,000	224,500,000
generalAndAdministrativeExpenses	1,211,000	678,000	45,880,000	3,955,000	4,436,000	78,200,000	88,900,000	118,300,000	--	--
sellingGeneralAndAdministrativeExpenses	35,912,000	37,018,000	45,880,000	61,392,000	78,399,000	78,200,000	88,900,000	118,300,000	189,700,000	224,500,000
operatingExpenses	43,858,000	47,072,000	55,799,000	74,213,000	96,964,000	94,200,000	106,200,000	144,300,000	217,500,000	280,600,000
operatingIncome	42,848,000	43,313,000	45,727,000	46,318,000	55,136,000	68,800,000	77,600,000	36,500,000	7,100,000	-10,200,000
totalOtherIncomeExpensesNet	46,000	238,000	372,000	-906,000	-3,262,000	300,000	-21,200,000	-28,100,000	-2,400,000	-5,400,000
ebitda	48,722,000	50,264,000	53,765,000	56,769,000	67,225,000	82,000,000	93,000,000	66,400,000	47,400,000	42,700,000
depreciationAndAmortization	5,828,000	6,713,000	8,038,000	11,355,000	15,326,000	13,200,000	15,400,000	29,900,000	40,300,000	52,900,000
interestIncome	129,000	238,000	372,000	146,000	162,000	300,000	600,000	700,000	300,000	400,000
interestExpense	46,000	238,000	372,000	2,000	25,000	--	300,000	2,800,000	1,700,000	5,400,000
incomeBeforeTax	42,894,000	43,551,000	46,099,000	45,412,000	51,874,000	69,100,000	56,400,000	8,400,000	4,700,000	-15,600,000
incomeTaxExpense	10,236,000	9,506,000	8,715,000	7,983,000	9,517,000	6,900,000	11,400,000	-4,100,000	300,000	-7,100,000
netIncome	32,658,000	34,045,000	37,384,000	37,429,000	42,357,000	62,200,000	45,000,000	14,600,000	4,400,000	-8,500,000
eps	0.17	0.17	0.19	0.19	0.21	0.3	0.22	0.07	--	-0.037
epsdiluted	0.16	0.17	0.19	0.19	0.21	0.3	0.22	0.07	--	-0.037
weightedAverageShsOut	197,743,410	198,858,251	199,978,991	201,147,931	202,655,252	204,200,000	204,900,000	207,600,000	--	228,700,000
weightedAverageShsOutDil	199,919,941	200,018,181	201,277,468	202,002,867	204,223,853	205,800,000	206,700,000	209,600,000	--	228,700,000
costAndExpenses	79,358,000	84,641,000	98,306,000	125,355,000	161,962,000	164,400,000	182,900,000	224,100,000	308,300,000	371,800,000
otherExpenses	--	--	--	--	--	--	6,600,000	8,600,000	--	--

Key Facts

Industry

Biotechnology

Sector

Healthcare

Headquarters

Cambridge, , GB

Website

abcam.com

CEO

Mr. Alan Thomas Hirzel BS, M.B.A., M.S., MBA, MS

Employees

1760

About the Company

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.